Old Web
English
Sign In
Acemap
>
Paper
>
PV-0428: Factor 2.5 radiosensitivity difference determined by ex vivo γH2AX assay in prostate cancer patients
PV-0428: Factor 2.5 radiosensitivity difference determined by ex vivo γH2AX assay in prostate cancer patients
2016
C. De-Colle
A. Menegakis
Arndt-Christian Mueller
Ala Yaromina
Joerg Hennenlotter
Arnulf Stenzl
Marcus Scharpf
Falko Fend
Umberto Ricardi
M. Baumann
D. Zips
Keywords:
Radiology
Prostate cancer
Ex vivo
Medicine
Radiosensitivity
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]